At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 26 enrolled
Drug / intervention
Abemaciclibdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1 Study of Abemaciclib in Native Chinese Patients With Advanced and/or Metastatic Cancers
In Brief
A Phase 1 clinical trial evaluating Abemaciclib for Advanced Cancer and Metastatic Cancer. Completed, enrolled 26 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine the safety of the study drug known as abemaciclib in native Chinese participants with advanced and/or metastatic cancers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Cancer, Metastatic Cancer
CountriesChina
Collaborators--
Timeline
Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartAug 2017
Primary CompletionNov 2018
Study CompletionSep 2019
TodayJul 2026
First PostedSep 29, 2016
Enrollment StartAug 7, 2017
Primary CompletionNov 23, 2018
Study CompletionSep 3, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.8 years ago
Interventions
Abemaciclibdrug
Administered orally